MétaCan
Menu
Back to cohort
Record W4414566957 · doi:10.1055/s-0045-1812149

Therapeutic Potential of Cannabinoids in Pediatric Dystonia: Insights from a Systematic Review and Clinical Cases

2025· article· en· W4414566957 on OpenAlexaff
Y. Schipper, Richard D. Reitman, Carolina Gorodetsky, A. Ménétrey, Sebastian Grunt

Bibliographic record

VenueNeuropediatrics · 2025
Typearticle
Languageen
FieldMedicine
TopicCannabis and Cannabinoid Research
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMEDLINEClinical trialSystematic reviewRimonabantClinical neurology

Abstract

fetched live from OpenAlex

Background/Purpose: Dystonia is a movement disorder characterized by sustained or intermittent involuntary muscle contractions, causing contorted movements or abnormal posturing. Symptoms often significantly impair quality of life, yet current pharmacological treatments are limited and frequently insufficient. Interestingly, cannabinoids have emerged as promising therapeutics; however, clinical evidence supporting their use, particularly in pediatric populations, remains sparse. This study presents a comprehensive systematic review of existing literature, complemented by an analysis of the largest cohort of pediatric patients treated with cannabinoids for dystonia. Methods: A systematic review was conducted following PRISMA guidelines, searching PubMed, EMBASE, and Cochrane for peer-reviewed studies published up to December 2024 on medical cannabinoid use in pediatric dystonia. In parallel, data from The Hospital for Sick Children were retrospectively analyzed, including 36 pediatric dystonia patients treated with cannabinoids. The patients were then categorized according to demographic information, clinical presentations, and genetic diagnoses and evaluated for functional improvement and adverse effects. Results: The systematic review identified six primary studies, which generally reported positive effects. In contrast, the cohort (mean age: 7.1 years, range: 2–14; equal male/female ratio) included a variety of genetic etiologies (e.g., MECP2, ATP1A3, KCNQ2, MCT8, and GABRA1) and nongenetic causes, including hypoxic-ischemic brain injuries. Preliminary findings show that while some patients experienced symptomatic relief with cannabinoid treatment, many outcomes remain inconclusive. Conclusion: While our systematic review suggests that cannabinoids consistently improve dystonia symptoms, our cohort study highlights the variability in response and a substantial proportion of unknown outcomes. Larger, prospective trials are needed to validate these early findings. Publication History Article published online: 26 September 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.014
Threshold uncertainty score0.031

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.024
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.004
Bibliometrics0.0140.013
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.326
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuropediatricsSame topicCannabis and Cannabinoid ResearchFrench-language works237,207